Target intelligence / Profile preview

Meprin A subunit alpha pseudogene

Molecular classification
Pseudogene
01

Overview

Meprin A subunit alpha pseudogene (ENSG00000284611) is a pseudogene related to the functional meprin A subunit alpha gene (MEP1A), which encodes one of the subunits of the meprin A oligomeric metalloprotease complex[1][2][3][4][9]. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional; they do not encode active proteins due to mutations or lack of regulatory elements. Meprin A subunit alpha pseudogenes have been annotated in the human genome (for example, *MEP1AP4*)[7], but do not produce protein and have no known role as drug targets, enzymes, receptors, or biomarkers. Therefore, ENSG00000284611 is not a therapeutic target and should not be used as such. The functional protein-coding version is *MEP1A* (meprin A subunit alpha), which is a metalloprotease involved in proteolysis and some disease processes like inflammatory bowel disease[1][3][4][9]. Pseudogenes like ENSG00000284611 differ from functional genes in that they do not produce an active protein product and hence lack biological functions or clinical roles[7]. There are no approved drugs, disease associations, or mechanisms of action for this pseudogene. If you intended the functional meprin A subunit alpha protein (MEP1A, ENSG00000112818), please clarify, as this may yield therapeutic relevance.

Other names
Meprin A alpha pseudogeneMEP1A pseudogenemeprin A subunit alpha pseudogene 4

Beyond the preview

Go deeper on Meprin A subunit alpha pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meprin A subunit alpha pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call